电子邮件 | usi***@***.com | 获取Email |
---|
电子邮件 | usi***@***.com | 获取Email |
---|
Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company's singular mission is to improve and prolong the lives of patients suffering from this disease. Launched in 2016 after years of research supported by Stanford's SPARK program, Eidos is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment to market as quickly as possible.
公司 | Eidos Therapeutics |
---|---|
职位 | Chief Scientific Officer |
地点 | United States |
http://www.linkedin.com/in/uma-sinha-1751282 | |
部门 | master_engineering_technical |
头衔 | Chief Scientific Officer at BridgeBio Pharma |
Eidos Therapeutics Chief Scientific Officer
2016-06-01 -
BridgeBio Chief Scientific Officer
2016-04-01 -
Global Blood Therapeutics Chief Scientific Officer
2014-01-01 - 2015-06-01
Global Blood Therapeutics Senior Vice President, Research
2013-01-01 - 2014-01-01
Portola Pharmaceuticals Vice President, Head of Biology
2004-04-01 - 2012-12-01
Uma Sinha 在 Eidos Therapeutics 担任 Chief Scientific Officer at BridgeBio Pharma
Uma Sinha 在 Eidos Therapeutics 的职位是 Chief Scientific Officer at BridgeBio Pharma
Uma Sinha 的电子邮件地址是 usi***@***.com
Uma Sinha 的电话号码是 -
Uma Sinha 的公司电话号码是 +165****
Uma Sinha 在 biotechnology 工作。
Uma Sinha 的一些同事包括Tanya Oshea、Wil Cainglet、Matt Masek、Marissa VJustin Collaco、。
Uma Sinha联系方式: 电子邮件地址:usi***@***.com 电话号码:-
Uma Sinha 的个人领英是:http://www.linkedin.com/in/uma-sinha-1751282
Uma Sinha 的办公地点:101 montgomery street, san francisco, california, united states
Top-ranked on G2 Crowd
全球B2B企业库 海关贸易数据 展会采购数据
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd